Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs
- 2 June 2023
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 84 (5) , 455-460
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancerClinical Epigenetics, 2022
- Prostate cancer reactivates developmental epigenomic programs during metastatic progressionNature Genetics, 2020
- Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancersEndocrine-Related Cancer, 2019
- Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC AlterationsEuropean Urology Oncology, 2019
- Integrative epigenetic taxonomy of primary prostate cancerNature Communications, 2018
- The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisNature Genetics, 2015
- Gleason Score 6 Adenocarcinoma: Should It Be Labeled As Cancer?Journal of Clinical Oncology, 2012
- Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?American Journal of Surgical Pathology, 2012
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974